-- 週五,原油基準價格漲跌互現,市場權衡著美伊在巴基斯坦重啟和平努力與不斷升級的海上衝突之間的關係。 布蘭特原油期貨上漲0.6%,至每桶105.73美元;穆爾班原油期貨下跌1.7%,至每桶104.11美元。 交易員們在不斷加劇的地緣政治風險和一線外交希望之間尋求平衡。 美國總統川普週四在社群媒體上發文,確認將以色列和黎巴嫩之間的停火協議延長三週。 他表示,美國將與黎巴嫩政府直接合作,加強對真主黨的防禦。 根據路透社報道,一位巴基斯坦政府消息人士透露,伊朗外長阿巴斯·阿拉格奇將於週五晚間抵達伊斯蘭堡,這無疑為外交進展注入了新的動力。 報道稱,一個伊朗小團隊計劃與已在當地的美國代表舉行第二輪和平談判。 然而,霍爾木茲海峽不斷升級的敵對行動持續支撐著全球油價。 週四,伊朗公佈了一段視頻,顯示其突擊隊員乘坐快艇強攻一艘大型貨船,以此鞏固其對這一全球20%油氣運輸咽喉要道的控制。 儘管外交斡旋頻繁,但川普總統在Truth Social社交媒體平台上發文稱,他不會為結束衝突設定“時間表”,而是尋求與德黑蘭達成“大協議”。這表明他已做好長期對峙的準備。 盛寶銀行分析師警告稱,即使達成和平協議,也無法立即緩和局勢。 他們預測,全球航運正常化需要數月時間,這將持續加劇柴油和航空燃油市場的供應緊張。 同時,地區局勢依然動盪,以色列警告稱,如果伊斯蘭堡會談未能取得突破,以色列仍準備重啟對伊朗目標的打擊。
Related Articles
Research Alert: CFRA Keeps Buy Opinion On Shares Of The Hartford Insurance Group, Inc.
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We trim our 12-month target price by $8 to $155, valuing HIG shares at 11.3x our 2026 operating EPS estimate of $13.75 (cut by $0.45) and at 10.6x our 2027 EPS estimate of $14.65 (cut by $0.30), vs. the shares' one-year average forward multiple of 10.3x and peer average of 13x. Q1 EPS of $3.09 vs. $2.20 a year ago missed our $3.60 estimate and $3.39 consensus view. Operating revenue growth of 6.2% was in line with our 6%-10% forecast, amid 5.3% earned premium growth, 13% higher net investment income, and 7.9% fee revenue growth. Q1 written premium growth of 4% and full-year 2025 growth of 7% bode well for 2026 revenue trends as premiums are earned. Underwriting results improved significantly, with Personal Lines combined ratio improving to 87.7% from 106.1% and underlying combined ratio to 85.0% from 89.7%. Business Insurance combined ratio was stable at 94.8%. Weighing the Q1 EPS miss with HIG's decent top-line growth and discounted valuation to peers, we view the shares as undervalued.
Research Alert: CFRA Keeps Strong Buy Opinion On Shares Of Baker Hughes
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We raise our 12-month target price by $14 to $82, reflecting a combination of our sum-of-the-parts (SOTP) and DCF models. For our SOTP model, we presume the oilfield services business (about 50% of BKR's franchise) to be valued at about 10x projected 2027 EBITDA (in line with major peers) and its industrial energy technology business (the other 50%) valued at 14x projected 2027 EBITDA (in line with the peer median). This blended approach, yielding a 12x multiple, implies a value of $73 per share. Meanwhile, our DCF model, using medium-term free cash flow growth of 5% per year, terminal growth of 2.5%, discounted at a WACC of 6.3%, yields intrinsic value of $91 per share. We cut our 2026 EPS estimate by $0.47 to $2.48, but we raise 2027's by $0.07 to $3.24. We acknowledge that the oilfield services business is likely to struggle in 2026 owing to the U.S.-Iran conflict, but the IET business appears quite robust and likely to be a source of both accelerating revenue growth and margins.
Research Alert: CFRA Maintains Hold Opinion In Shares Of Wab
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lift our 12-month target to $285 from $275 following WAB's Q1 earnings print, valuing shares at 24.2x our 2027 EPS outlook of $11.76 (revised from $11.46; 2026 EPS estimate up to $10.57 from $10.50), a slight premium to WAB's long-term historical multiple average given structural improvements in earnings quality. While we are cautious on signs of overcapacity in the freight market, an elevated order backlog (12-month sits at over $9 billion), internal initiatives to shore up margins, and potential synergies from M&A activity positions WAB to continue growing earnings at double-digit rates in 2026-2027, in our view. Despite tariff-related cost pressures, WAB has done a commendable job of defending margins via a mix of pricing, lean manufacturing, and pruning of lower-profit operations. Q1 results were mixed but overall positive, in our view. We maintain our Hold recommendation on shares.